Effect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson’s Disease

Table 5

Changes in the levels of neuroinflammatory factors and neurotransmitters in serum in the D + EA and D groups.

	D + EA group (after and before EA)	D group (after and before 2 months)
Neuroinflammatory factors
NO [mmol/L, median (quartile)]	53.181 (6.421~64.505)	80.494 (62.154~107.569)	0.003
IL-1β [pg/mL, median (quartile)]	2.083 (−0.938~5.337)	2.525 (−3.358~4.034)	0.425
PGE2 [pg/mL, median (quartile)]	1.373 (−35.700~6.699)	1.436 (−2.378~6.738)	0.215
TNF-α [pg/mL, median (quartile)]	8.643 (−22.139~62.882)	20.537 (−17.089~52.414)	0.773
Neurotransmitters
NE [μg/mL, median (quartile)]	1.234 (0.734~1.512)	1.208 (0.609~1.878)	0.808
Ach [nmol/L, median (quartile)]	0.007 (0.002~0.011)	0.008 (0.003~0.015)	0.603
DA [μg/mL, median (quartile)]	1.429 (0.518~3.035)	1.795 (1.161~2.683)	0.764
5-HT [μg/mL, median (quartile)]	0.077 (−0.294~0.506)	0.703 (0.109~0.981)	0.055

Values are median (lower quartile, upper quartile) for the Kruskal-Wallis test.
.